Fmoc-(R)-3-Amino-4-(2-thienyl)-butyric acid, 97%, 100mg

(S)-2-Amino-2-(3-bromo-4-chlorophenyl)ethan-1-ol hydrochloride, 98+%, 100mg

7-Azaindol, mínimo 98%, 1 g, envase de vidrio

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

(S)-2-Amino-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 100mg

N-(3,5-Dimethyladamantan-1-yl)formamide, 97.0%, 250mg

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole, 97%, 100mg

N,N-Dimethyl-1-(5-methyl-1H-indol-3-yl)methanamine, 95.0%, 25g

tert-Butyl (4-chloro-3-formylpyridin-2-yl)carbamate, 95.0%, 100mg

(1H-Pyrrolo[2,3-b]pyridin-4-yl)methanol, 95.0%, 25g

(S)-4-N-Boc-Piperazine-2-carboxylic acid, 97.0%, 1g

Lithium Tricyanomethanide - Acetonitrile Complex>98.0%(T)1g

Sodium tetrafluoroborate, 98.0%, 100g